"Driven by Innovation in Biologics and Expanding Therapeutic Applications, the Global Pharmaceutical Drugs Market Continues to Evolve—Spanning Prescription, OTC, Generics, and Biologics to Address ...

The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...

PRNewswire/ - Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to ...

Previous attempts at treatments have faced many limitations but Amphix Bio is taking a completely new approach to neural regeneration, with the potential for a breakthrough in the field." 1 Amfx-200 ...

In a field where treatment options are limited and rapid disease progression remains difficult to manage, Alterity ...